Support Us — Your donation helps us keep running

Goal: 1000 CNY,Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2024-6796
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Vulnerability in Baxter Connex Health Portal
Source: NVD (National Vulnerability Database)
Vulnerability Description
In Baxter Connex health portal released before 8/30/2024, an improper access control vulnerability has been found that could allow an unauthenticated attacker to gain unauthorized access to Connex portal's database and/or modify content.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
Source: NVD (National Vulnerability Database)
Vulnerability Type
访问控制不恰当
Source: NVD (National Vulnerability Database)
Vulnerability Title
Baxter Connex Health Portal 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Baxter Connex Health Portal是美国百特(Baxter)公司的一个医疗仪器的门户网站。 Baxter Connex Health Portal存在安全漏洞,该漏洞源于包含一个不适当的访问控制漏洞,可能允许未经身份验证的攻击者获得对 Connex 门户数据库的未经授权的访问和/或修改内容。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
BaxterConnex Health Portal 0 ~ 8/30/2024 -
II. Public POCs for CVE-2024-6796
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2024-6796
Please Login to view more intelligence information
New Vulnerabilities
V. Comments for CVE-2024-6796

No comments yet


Leave a comment